(lp0
S'Licensing Agreements Drive Ligand Pharmaceuticals Inc. 13% Higher in July Motley Fool - Aug 8, 2016 What: Shares of Ligand Pharmaceuticals , an acquirer of royalty assets in the biotech space, surged 13% in July, according to data from S&amp;P Global Market Intelligence.'
p1
aS"Here's Why Ligand Pharmaceuticals Inc Is Plunging Today Motley Fool - Sep 27, 2016 Shares of Ligand Pharmaceuticals , an owner of royalty assets in the healthcare space, are falling by more than 13% as of 3:30 p.m.Amgen's Multiple Myeloma Drug Bumbles Key Test Vs. Blockbuster Velcade - Investor's Business Daily"
p2
aS'Ligand Pharmaceuticals Inc Reports 31% Increase In Q4 Bottom Line Nasdaq - Feb 23, 2017  - Ligand Pharmaceuticals Inc  reported earnings for its fourth quarter that climbed compared to the same period last year.'
p3
aS'Lawsuit for Investors in Ligand Pharmaceuticals Inc.  over ... GlobeNewswire  - Nov 29, 2016 SAN DIEGO, Nov. 29, 2016  -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in California on behalf of certain purchasers of shares of Ligand Pharmaceuticals Inc.  over alleged Securities Laws&nbsp;...'
p4
aS'Ligand Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for LGND Nasdaq - Mar 10, 2017 In trading on Friday, shares of Ligand Pharmaceuticals Inc  crossed above their 200 day moving average of $109.46, changing hands as high as $109.59 per share.'
p5
aS'Ligand Pharmaceuticals Inc. Investigated For Securities Fraud By Block ... PR Newswire  - Nov 16, 2016 BOSTON, Nov. 15, 2016 /PRNewswire/ -- Block &amp; Leviton LLP , a securities litigation firm representing investors nationwide, is investigating whether Ligand Pharmaceuticals Inc.  and certain of its officers and directors&nbsp;...'
p6
aS"Analyst Update: Alphabet Inc, Facebook Inc, and Ligand Pharmaceuticals Inc. Schaeffers Research  - Sep 27, 2016 Analysts are weighing in on internet issue Alphabet Inc , social media stock Facebook Inc , and drugmaker Ligand Pharmaceuticals Inc. . Here's a quick roundup of today's brokerage notes on GOOGL, FB,&nbsp;..."
p7
aS'How Do Analysts Rate Ligand Pharmaceuticals? Market Realist - Jul 14, 2016 Ligand Pharmaceuticals  is based in La Jolla, California. LGND is a biopharmaceutical company that develops and acquires technologies that are useful to pharmaceutical companies for drug discovery and development. Ligand Pharmaceuticals has&nbsp;...'
p8
aS"Understanding Ligand Pharmaceuticals's PE Multiple Market Realist - Jul 14, 2016 If you are a risk-averse investor and still want to enjoy exposure to a growth-stage biopharmaceutical company such as Ligand Pharmaceuticals, you can invest in ETFs. The PowerShares Dynamic Pharmaceuticals Portfolio ETF  holds ~4.0% weight in&nbsp;..."
p9
aS'Sermonix Pharmaceuticals Secures Worldwide Rights to Oral Lasofoxifene From ... Marketwired  - Feb 28, 2017 COLUMBUS, OH-- - Sermonix Pharmaceuticals LLC, a privately held biotechnology company focused on the development and commercialization of female-specific oncology products, today announced it licensed worldwide&nbsp;...Ligand Pharmaceuticals Incorporated  Moves Higher on Volume Spike for ... - Equities.comLigand Pharmaceuticals Inc.  Releases FY Earnings Guidance - Chaffey Breeze'
p10
a.